Modeling the heterogeneous intestinal absorption of propiverine extended-release

被引:4
|
作者
Weiss, Michael [1 ,2 ]
Sermsappasuk, Pakawadee [2 ]
Siegmund, Werner [3 ]
机构
[1] Univ Halle Wittenberg, Dept Pharmacol, D-06097 Halle, Saale, Germany
[2] Naresuan Univ, Fac Pharmaceut Sci, Phitsanulok, Thailand
[3] Ernst Moritz Arndt Univ Greifswald, Div Clin Pharmacol, Inst Pharmacol, Greifswald, Germany
关键词
Heterogenous absorption; Propiverine; Bioavailability; Dissolution time; DRUG ABSORPTION; EXPRESSION; IMMEDIATE; TRANSIT;
D O I
10.1016/j.ejps.2015.05.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Propiverine is a widely used antimuscarinic drug with bioavailability that is limited by intestinal first-pass extraction. To study the apparent heterogeneity in intestinal first-pass extraction, we performed a population analysis of oral concentration-time data measured after administration of an extended-release formulation of propiverine in ten healthy subjects. Using an inverse Gaussian function as input model, the assumption that the systemically available fraction increases as a sigmoidal function of time considerably improved the fit. The step-like increase in this fraction at time t = 3.7 h predicted by the model suggests that propiverine is predominantly absorbed in colon. A nearly perfect correlation was found between the estimates of bioavailability and mean dissolution time. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 50 条
  • [1] Influence of a Fat-Rich Meal on Bioavailability of Extended-Release and Immediate-Release Propiverine
    Siegmund, Werner
    Siegert, Joachim
    Richter, Klaus
    Schnabel, Frieder
    Feustel, Cornelia
    Kirch, Wilhelm
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (05): : 681 - 690
  • [2] Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination
    Karen May
    Thomas Giessmann
    Danilo Wegner
    Reinhard Oertel
    Christiane Modess
    Stefan Oswald
    Manfred Braeter
    Werner Siegmund
    European Journal of Clinical Pharmacology, 2008, 64
  • [3] Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination
    May, Karen
    Giessmann, Thomas
    Wegner, Danilo
    Oertel, Reinhard
    Modess, Christiane
    Oswald, Stefan
    Braeter, Manfred
    Siegmund, Werner
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (11) : 1085 - 1092
  • [4] Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity
    M Stöhrer
    G Mürtz
    G Kramer
    W Warnack
    G Primus
    V Jinga
    A Manu-Marin
    N Calomfirescu
    G Strugala
    Spinal Cord, 2013, 51 : 419 - 423
  • [5] Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity
    Stoehrer, M.
    Muertz, G.
    Kramer, G.
    Warnack, W.
    Primus, G.
    Jinga, V.
    Manu-Marin, A.
    Calomfirescu, N.
    Strugala, G.
    SPINAL CORD, 2013, 51 (05) : 419 - 423
  • [6] Physiologically Based Absorption Modeling to Design Extended-Release Clinical Products for an Ester Prodrug
    Ding, Xuan
    Day, Jeffrey S.
    Sperry, David C.
    AAPS JOURNAL, 2016, 18 (06): : 1424 - 1438
  • [7] Physiologically Based Absorption Modeling to Design Extended-Release Clinical Products for an Ester Prodrug
    Xuan Ding
    Jeffrey S. Day
    David C. Sperry
    The AAPS Journal, 2016, 18 : 1424 - 1438
  • [8] Approaches to Account for Colon Absorption in Physiologically Based Biopharmaceutics Modeling of Extended-Release Drug Products
    Jadhav, Harshad
    Augustijns, Patrick
    Tannergren, Christer
    MOLECULAR PHARMACEUTICS, 2023, 20 (12) : 6272 - 6288
  • [9] Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity
    Yanovski, Susan Z.
    Yanovski, Jack A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (12): : 1213 - 1214
  • [10] Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed-Release and Extended-Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations
    Incledon, Bev
    Incledon, Chantal
    Gomeni, Roberto
    Uchida, Cassandra L.
    Morris, Amy
    Perry, Kim
    Kapuscinski, Jill
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 966 - 975